Emerging Trends and Advances in Interventional Cardiology

A special issue of Journal of Cardiovascular Development and Disease (ISSN 2308-3425). This special issue belongs to the section "Cardiovascular Clinical Research".

Deadline for manuscript submissions: 30 June 2025 | Viewed by 695

Special Issue Editors


E-Mail Website
Guest Editor
2nd Cardiology Department, Interbalkan Medical Center, 55535 Thessaloniki, Greece
Interests: transcatheter mitral valve replacement and repair; transcatheter therapy of heart failure; transcatheter tricuspid valve replacement and repair

E-Mail
Guest Editor
2nd Cardiology Department, Interbalkan Medical Center, 55535 Thessaloniki, Greece
Interests: interventional cardiology; structural heart disease; pulmonary hypertension

Special Issue Information

Dear Colleagues,

This Special Issue focuses on the latest innovations and evolving trends in interventional cardiology. It aims to highlight cutting-edge techniques, devices, and approaches that are transforming the management of cardiovascular diseases. Topics of interest include advances in percutaneous coronary interventions (PCIs), structural heart interventions, transcatheter valve therapies, and novel imaging modalities. This Special Issue also seeks to explore emerging data on the long-term outcomes of these interventions and their impact on clinical practice. Contributions from clinical trials, technological advancements, and expert reviews will provide valuable insights for practitioners and researchers shaping the future of cardiovascular care.

Dr. Vlasis Ninios
Dr. Georgios Papadopoulos
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Cardiovascular Development and Disease is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • interventional cardiology
  • coronary artery disease
  • structural heart disease
  • percutaneous coronary intervention
  • aortic stenosis
  • mitral regurgitation
  • tricuspid regurgitation

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

11 pages, 608 KiB  
Article
Indications, Management, and Short- and Medium-Term Outcomes of Patients with Chronic Coronary Occlusion Treated with Percutaneous Revascularization—A Single-Center Study
by Lucia Barbieri, Gabriele Tumminello, Lorenzo Mafrici, Guido Pasero, Luca Mircoli, Federico Colombo, Cecilia Gobbi, Alessandra S. Rizzuto and Stefano Carugo
J. Cardiovasc. Dev. Dis. 2025, 12(2), 75; https://doi.org/10.3390/jcdd12020075 - 16 Feb 2025
Viewed by 395
Abstract
The diagnosis of chronic total occlusion (CTO), characterized by the complete obstruction of a coronary artery for at least three months, remains challenging and can be entirely asymptomatic. Since the indications for performing a recanalization procedure for CTO do not originate from randomized [...] Read more.
The diagnosis of chronic total occlusion (CTO), characterized by the complete obstruction of a coronary artery for at least three months, remains challenging and can be entirely asymptomatic. Since the indications for performing a recanalization procedure for CTO do not originate from randomized controlled trials, this study aimed to assess the indications, management, and procedural outcomes of patients undergoing percutaneous revascularization (PCI) for a CTO, ensuring that the population was as uniform as possible regarding technologies and methodological approaches. Forty-one consecutive patients who underwent PCI for CTO recanalization were enrolled from January 2021 to 2024. Additional outcomes included mortality, major adverse cardiovascular events, and the presence of residual cardiac symptoms, with a median follow-up of 449 days and an interquartile range of 230–643 days. Our real-life study confirmed that PCI for CTO has a high success rate and a low incidence of major complications. Full article
(This article belongs to the Special Issue Emerging Trends and Advances in Interventional Cardiology)
Show Figures

Figure 1

Back to TopTop